30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Immune Pharmaceuticals Inc (IMNPQ)

Track

Stock chart
Ticker: IMNPQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Fiorino Anthony S.
1 sale — total 263 USD
Sale 3 Feb 2020
Value US$1,807,423.56 | Price 470.80 | Shares 50,560
Buy 22 May 2018
Value US$1,104,475.96 | Price 247.45 | Shares 84,262
Buy 17 May 2018
Value US$12,900.00 | Price 0.26 | Shares 50,000
Buy 4 Jan 2017
Value US$14,221.91 | Price 0.19 | Shares 76,503
Buy 16 Dec 2016
Value US$29,999.98 | Price 0.19 | Shares 161,377
Buy 4 Aug 2016
Value US$356,250.00 | Price 0.38 | Shares 937,500
Buy 4 Aug 2016
Value US$350,000.10 | Price 0.45 | Shares 777,778
Buy 4 Aug 2016
Value US$300,000.15 | Price 0.45 | Shares 666,667
Planned buy 26 Jan 2016
Value US$24,826.20 | Price 0.59 | Shares 42,000
Planned buy 19 Jan 2016
Value US$24,999.52 | Price 0.57 | Shares 44,200
Planned buy 12 Jan 2016
Value US$24,597.42 | Price 0.62 | Shares 39,400
Planned buy 5 Jan 2016
Value US$49,972.00 | Price 0.81 | Shares 62,000
Buy 7 Dec 2015
Value US$117,105.00 | Price 0.78 | Shares 150,000
Buy 7 Dec 2015
Value US$49,926.36 | Price 0.76 | Shares 65,400
Buy 14 Sep 2015
Value US$73,480.00 | Price 1.47 | Shares 50,000
Buy 14 Sep 2015
Value US$73,850.00 | Price 1.48 | Shares 50,000
Buy 1 Sep 2015
Value US$9,798.83 | Price 1.29 | Shares 7,569
Buy 26 Nov 2014
Value US$20,000.00 | Price 2.50 | Shares 8,000
Buy 26 Nov 2014
Value US$20,000.00 | Price 2.50 | Shares 8,000
Buy 26 Nov 2014
Value US$20,000.00 | Price 2.50 | Shares 8,000
Buy 26 Nov 2014
Value US$10,000.00 | Price 2.50 | Shares 4,000
Buy 26 Nov 2014
Value US$26,000.00 | Price 2.50 | Shares 10,400
Buy 13 Dec 2007
Value US$4,088.10 | Price 1.36 | Shares 3,000
Buy 13 Dec 2007
Value US$9,450.00 | Price 1.35 | Shares 7,000
Buy 13 Dec 2007
Value US$7,100.00 | Price 1.42 | Shares 5,000
Buy 13 Dec 2007
Value US$6,750.00 | Price 1.35 | Shares 5,000
Buy 13 Dec 2007
Value US$7,200.00 | Price 1.44 | Shares 5,000
Buy 13 Dec 2007
Value US$6,750.00 | Price 1.35 | Shares 5,000
Buy 13 Dec 2007
Value US$6,750.00 | Price 1.35 | Shares 5,000
Buy 13 Dec 2007
Value US$21,000.00 | Price 1.40 | Shares 15,000
Buy 12 Dec 2007
Value US$3,550.00 | Price 1.42 | Shares 2,500
Buy 12 Dec 2007
Value US$10,725.00 | Price 1.43 | Shares 7,500
Buy 12 Dec 2007
Value US$7,000.00 | Price 1.40 | Shares 5,000
Buy 12 Dec 2007
Value US$14,100.00 | Price 1.41 | Shares 10,000
Buy 12 Dec 2007
Value US$2,556.00 | Price 1.42 | Shares 1,800
Buy 11 Dec 2007
Value US$47,476.00 | Price 1.43 | Shares 33,200
Buy 13 Sep 2007
Value US$972.00 | Price 1.62 | Shares 600
Buy 4 Sep 2007
Value US$3,360.00 | Price 1.68 | Shares 2,000
Buy 30 Aug 2007
Value US$1,535.10 | Price 1.70 | Shares 903
Buy 30 Aug 2007
Value US$1,512.00 | Price 1.68 | Shares 900
Buy 29 Aug 2007
Value US$13,607.02 | Price 1.66 | Shares 8,197
Buy 28 Aug 2007
Value US$14,685.00 | Price 1.65 | Shares 8,900
Buy 28 Aug 2007
Value US$1,804.00 | Price 1.64 | Shares 1,100
Buy 24 Aug 2007
Value US$2,400.00 | Price 1.60 | Shares 1,500
Buy 23 Aug 2007
Value US$972.00 | Price 1.62 | Shares 600
Buy 23 Aug 2007
Value US$640.00 | Price 1.60 | Shares 400
Buy 21 Aug 2007
Value US$3,220.00 | Price 1.61 | Shares 2,000
Buy 21 Aug 2007
Value US$3,703.00 | Price 1.61 | Shares 2,300
Buy 21 Aug 2007
Value US$3,542.00 | Price 1.61 | Shares 2,200
Buy 21 Aug 2007
Value US$4,680.00 | Price 1.56 | Shares 3,000
Buy 21 Aug 2007
Value US$11,060.00 | Price 1.58 | Shares 7,000
Buy 21 Aug 2007
Value US$4,770.00 | Price 1.59 | Shares 3,000
Buy 21 Aug 2007
Value US$4,800.00 | Price 1.60 | Shares 3,000
Buy 21 Aug 2007
Value US$9,821.00 | Price 1.61 | Shares 6,100
Buy 20 Aug 2007
Value US$1,727.00 | Price 1.57 | Shares 1,100
Buy 20 Aug 2007
Value US$1,422.00 | Price 1.58 | Shares 900
Buy 20 Aug 2007
Value US$1,570.00 | Price 1.57 | Shares 1,000
Buy 20 Aug 2007
Value US$1,106.00 | Price 1.58 | Shares 700
Buy 20 Aug 2007
Value US$1,570.00 | Price 1.57 | Shares 1,000
Buy 20 Aug 2007
Value US$1,264.00 | Price 1.58 | Shares 800
Buy 20 Aug 2007
Value US$785.00 | Price 1.57 | Shares 500
Buy 20 Aug 2007
Value US$790.00 | Price 1.58 | Shares 500
Buy 20 Aug 2007
Value US$1,590.00 | Price 1.59 | Shares 1,000
Buy 17 Aug 2007
Value US$3,925.00 | Price 1.57 | Shares 2,500
Buy 17 Aug 2007
Value US$1,580.00 | Price 1.58 | Shares 1,000
Buy 17 Aug 2007
Value US$795.00 | Price 1.59 | Shares 500
Buy 13 Jun 2006
Value US$807.00 | Price 2.69 | Shares 300
Buy 13 Jun 2006
Value US$12,690.00 | Price 2.70 | Shares 4,700
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-02-04 2020-02-03 S Sale
Fiorino Anthony S.
50,560 +45.1%
470.80
US$1,807,424 		50,560 +45.1% 470.80 US$1,807,424
2018-05-23 2018-05-22 B Purchase Fiorino Anthony S.

Chief Medical Officer and COO

Officer
84,262 -30.8%
247.45
US$1,104,476 		84,262 -30.8% 247.45 US$1,104,476
2018-05-18 2018-05-17 B Purchase Fiorino Anthony S.

Chief Medical Officer and COO

Officer
61,727 -11.7%
139.13
US$4,292,016 		61,727 -11.7% 139.13 US$4,292,016
2017-01-04 2017-01-04 B Purchase Kazado Daniel Non-Executive Director
76,503 +7.2%
0.19
US$14,222 		76,503 +7.2% 0.19 US$14,222
2016-12-20 2016-12-16 B Purchase Kazado Daniel Non-Executive Director
161,377 +17.8%
0.19
US$30,000 		161,377 +17.8% 0.19 US$30,000
2016-08-04 2016-08-04 B Purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
937,500 +19.5%
0.38
US$356,250 		937,500 +19.5% 0.38 US$356,250
2016-08-04 2016-08-04 B Purchase Luchi Monica E.

EVP & CMO

Officer
777,778 +inf%
0.45
US$350,000 		777,778 +inf% 0.45 US$350,000
2016-08-04 2016-08-04 B Purchase Kazado Daniel Non-Executive Director
666,667 +277.1%
0.45
US$300,000 		666,667 +277.1% 0.45 US$300,000
2016-01-26 2016-01-26 PP Planned purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
42,000 +0.9%
0.59
US$24,826 		42,000 +0.9% 0.59 US$24,826
2016-01-19 2016-01-19 PP Planned purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
44,200 +0.9%
0.57
US$25,000 		44,200 +0.9% 0.57 US$25,000
2016-01-12 2016-01-12 PP Planned purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
39,400 +0.8%
0.62
US$24,597 		39,400 +0.8% 0.62 US$24,597
2016-01-06 2016-01-05 PP Planned purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
62,000 +1.3%
0.81
US$49,972 		62,000 +1.3% 0.81 US$49,972
2015-12-08 2015-12-07 B Purchase Kazado Daniel Non-Executive Director
150,000 +165.5%
0.78
US$117,105 		150,000 +165.5% 0.78 US$117,105
2015-12-08 2015-12-07 B Purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
65,400 +1.4%
0.76
US$49,926 		65,400 +1.4% 0.76 US$49,926
2015-09-16 2015-09-14 B Purchase Kazado Daniel Non-Executive Director
50,000 +123.1%
1.47
US$73,480 		50,000 +123.1% 1.47 US$73,480
2015-09-16 2015-09-14 B Purchase AZRIA RENE PIERRE Non-Executive Director
50,000 +inf%
1.48
US$73,850 		50,000 +inf% 1.48 US$73,850
2015-09-01 2015-09-01 B Purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
7,569 +0.2%
1.29
US$9,799 		7,569 +0.2% 1.29 US$9,799
2014-12-03 2014-11-26 B Purchase Stancic Ana Non-Executive Director
8,000 +inf%
2.50
US$20,000 		8,000 +inf% 2.50 US$20,000
2014-12-03 2014-11-26 B Purchase Berdugo Gad Non-Executive Director
8,000 +inf%
2.50
US$20,000 		8,000 +inf% 2.50 US$20,000
2014-12-03 2014-11-26 B Purchase Kazado Daniel Non-Executive Director
8,000 +2040.8%
2.50
US$20,000 		8,000 +2040.8% 2.50 US$20,000
2014-12-03 2014-11-26 B Purchase Durrant Cameron Non-Executive Director
4,000 +inf%
2.50
US$10,000 		4,000 +inf% 2.50 US$10,000
2014-12-03 2014-11-26 B Purchase SIDRANSKY DAVID Non-Executive Director
10,400 +131.8%
2.50
US$26,000 		10,400 +131.8% 2.50 US$26,000
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
3,000 +4.5%
1.36
US$4,088 		3,000 +4.5% 1.36 US$4,088
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
7,000 +11.6%
1.35
US$9,450 		7,000 +11.6% 1.35 US$9,450
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
5,000 +9.1%
1.42
US$7,100 		5,000 +9.1% 1.42 US$7,100
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
5,000 +10.0%
1.35
US$6,750 		5,000 +10.0% 1.35 US$6,750
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
5,000 +11.1%
1.44
US$7,200 		5,000 +11.1% 1.44 US$7,200
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
5,000 +12.5%
1.35
US$6,750 		5,000 +12.5% 1.35 US$6,750
2007-12-13 2007-12-13 B Purchase COOK ROBERT W

CFO-SVP, Finance & Admin.

Officer
5,000 +50.0%
1.35
US$6,750 		5,000 +50.0% 1.35 US$6,750
2007-12-13 2007-12-13 B Purchase Talley John V

President, CEO & Director

Executive Director
15,000 +14.7%
1.40
US$21,000 		15,000 +14.7% 1.40 US$21,000
2007-12-14 2007-12-12 B Purchase BHAGWAT DILEEP

SVP-Pharmaceutical Development

Officer
2,500 +25.0%
1.42
US$3,550 		2,500 +25.0% 1.42 US$3,550
2007-12-14 2007-12-12 B Purchase BHAGWAT DILEEP

SVP-Pharmaceutical Development

Officer
7,500 +300.0%
1.43
US$10,725 		7,500 +300.0% 1.43 US$10,725
2007-12-14 2007-12-12 B Purchase Wiedemann Oliver

Managing Director-See Remarks

Officer
5,000 +inf%
1.40
US$7,000 		5,000 +inf% 1.40 US$7,000
2007-12-13 2007-12-12 B Purchase ALLARD STEPHANE

Chief Medical Officer

Officer
10,000 +28.1%
1.41
US$14,100 		10,000 +28.1% 1.41 US$14,100
2007-12-13 2007-12-12 B Purchase ALLARD STEPHANE

Chief Medical Officer

Officer
1,800 +5.3%
1.42
US$2,556 		1,800 +5.3% 1.42 US$2,556
2007-12-13 2007-12-11 B Purchase ALLARD STEPHANE

Chief Medical Officer

Officer
33,200 +5533.3%
1.43
US$47,476 		33,200 +5533.3% 1.43 US$47,476
2007-12-13 2007-09-13 B Purchase ALLARD STEPHANE

Chief Medical Officer

Officer
600 +inf%
1.62
US$972 		600 +inf% 1.62 US$972
2007-09-04 2007-09-04 B Purchase Bedard John F Non-Executive Director
2,000 +inf%
1.68
US$3,360 		2,000 +inf% 1.68 US$3,360
2007-08-30 2007-08-30 B Purchase COOK ROBERT W

CFO-SVP, Finance & Admin.

Officer
903 +9.9%
1.70
US$1,535 		903 +9.9% 1.70 US$1,535
2007-08-30 2007-08-30 B Purchase COOK ROBERT W

CFO-SVP, Finance & Admin.

Officer
900 +11.0%
1.68
US$1,512 		900 +11.0% 1.68 US$1,512
2007-08-30 2007-08-29 B Purchase COOK ROBERT W

CFO-SVP, Finance & Admin.

Officer
8,197 +inf%
1.66
US$13,607 		8,197 +inf% 1.66 US$13,607
2007-08-28 2007-08-28 B Purchase Talley John V

President, CEO & Director

Executive Director
8,900 +9.5%
1.65
US$14,685 		8,900 +9.5% 1.65 US$14,685
2007-08-28 2007-08-28 B Purchase Talley John V

President, CEO & Director

Executive Director
1,100 +1.2%
1.64
US$1,804 		1,100 +1.2% 1.64 US$1,804
2007-08-27 2007-08-24 B Purchase BHAGWAT DILEEP

SVP-Pharmaceutical Development

Officer
1,500 +150.0%
1.60
US$2,400 		1,500 +150.0% 1.60 US$2,400
2007-08-24 2007-08-23 B Purchase BHAGWAT DILEEP

SVP-Pharmaceutical Development

Officer
600 +150.0%
1.62
US$972 		600 +150.0% 1.62 US$972
2007-08-24 2007-08-23 B Purchase BHAGWAT DILEEP

SVP-Pharmaceutical Development

Officer
400 +inf%
1.60
US$640 		400 +inf% 1.60 US$640
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
2,000 +5.2%
1.61
US$3,220 		2,000 +5.2% 1.61 US$3,220
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
2,300 +6.4%
1.61
US$3,703 		2,300 +6.4% 1.61 US$3,703
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
2,200 +6.5%
1.61
US$3,542 		2,200 +6.5% 1.61 US$3,542
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
3,000 +9.8%
1.56
US$4,680 		3,000 +9.8% 1.56 US$4,680
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
7,000 +29.7%
1.58
US$11,060 		7,000 +29.7% 1.58 US$11,060
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
3,000 +14.6%
1.59
US$4,770 		3,000 +14.6% 1.59 US$4,770
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
3,000 +17.0%
1.60
US$4,800 		3,000 +17.0% 1.60 US$4,800
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
6,100 +53.0%
1.61
US$9,821 		6,100 +53.0% 1.61 US$9,821
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
1,100 +10.6%
1.57
US$1,727 		1,100 +10.6% 1.57 US$1,727
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
900 +9.5%
1.58
US$1,422 		900 +9.5% 1.58 US$1,422
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
1,000 +11.8%
1.57
US$1,570 		1,000 +11.8% 1.57 US$1,570
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
700 +9.0%
1.58
US$1,106 		700 +9.0% 1.58 US$1,106
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
1,000 +14.7%
1.57
US$1,570 		1,000 +14.7% 1.57 US$1,570
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
800 +13.3%
1.58
US$1,264 		800 +13.3% 1.58 US$1,264
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
500 +9.1%
1.57
US$785 		500 +9.1% 1.57 US$785
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
500 +10.0%
1.58
US$790 		500 +10.0% 1.58 US$790
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
1,000 +25.0%
1.59
US$1,590 		1,000 +25.0% 1.59 US$1,590
2007-08-20 2007-08-17 B Purchase SAVAGE ROBERT G Non-Executive Director
2,500 +166.7%
1.57
US$3,925 		2,500 +166.7% 1.57 US$3,925
2007-08-20 2007-08-17 B Purchase SAVAGE ROBERT G Non-Executive Director
1,000 +200.0%
1.58
US$1,580 		1,000 +200.0% 1.58 US$1,580
2007-08-20 2007-08-17 B Purchase SAVAGE ROBERT G Non-Executive Director
500 +inf%
1.59
US$795 		500 +inf% 1.59 US$795
2006-06-15 2006-06-13 B Purchase JACKSON GUY C Non-Executive Director
300 +inf%
2.69
US$807 		300 +inf% 2.69 US$807
2006-06-15 2006-06-13 B Purchase JACKSON GUY C Non-Executive Director
4,700 +inf%
2.70
US$12,690 		4,700 +inf% 2.70 US$12,690
Explore more

More insider trading research around Immune Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America